RASHA DABBOUSI: Open Payments
NPI 1427466291 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 36 payments from 12 companies in 2025. Trend: 2023 $819 · 2024 $744 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 13 | $261 |
| Journey Medical Corporation | 3 | $235 |
| LEO Pharma Inc. | 3 | $73 |
| GENZYME CORPORATION | 2 | $48 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $40 |
| PFIZER INC. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Lilly USA, LLC | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
Products named: OPZELURA, EMROSI, DUPIXENT, ANZUPGO, CIBINQO, Rhapsido, TALTZ, ADBRY.
Industry payments across AZ — which companies pay providers there.
